Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
W. Van der Graaf
Observed names:
Graaf, W. van der,
Van der Graaf, W,
W van der Graaf,
W. Graaf,
W. van der Graaf,
Wiebo van der Graaf
show all 6
Institution:
The Netherlands Cancer Institute
Observed institutions:
Università Cattolica del Sacro Cuore,
University Medical Center Groningen,
Institute of Cancer Research,
Radboud University Nijmegen,
Utrecht University,
Radboud University Medical Center,
The Netherlands Cancer Institute,
Royal Marsden Hospital
show all 8
OpenAlex ID:
A5111885836
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
·
P.G. Casali
, N. Abecassis
, et al.
·
Annals of Oncology
·
1,614
PDF
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
·
P.G. Casali
, N. Abecassis
, et al.
·
Annals of Oncology
·
750
Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target
2003
·
J Verweij
, A van Oosterom
, et al.
·
European Journal of Cancer
·
404
Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014)
2015
·
Blay, J.Y.
, Bertuzzi, A.
, et al.
·
Data Archiving and Networked Services (DANS)
·
59
EORTC–GCG process quality indicators for ovarian cancer surgery
2008
·
L. Verleye
, P.B. Ottevanger
, et al.
·
European Journal of Cancer
·
56
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network
2022
·
A. Smrke
, A.M. Frezza
, et al.
·
ESMO Open
·
37
PDF
Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells
2004
·
R. Komdeur
, C. Meijer
, et al.
·
International Journal of Oncology
·
26
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring
2013
·
S. Heskamp
, H. Laarhoven
, et al.
·
Current Molecular Medicine
·
11
Eosinophilia in patients with HIV‐1 infection
1994
·
Wiebo van der Graaf
, Jan C.C. Borleffs
·
European Journal Of Haematology
·
7
1629MO First-line chemotherapy (CT) in advanced well-differentiated/dedifferentiated liposarcoma (WD/DD LPS): An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
2020
·
S. Stacchiotti
, W. Van der Graaf
, et al.
·
Annals of Oncology
·
3
3401 Absence of progression, not extent of remission defines prognosis in soft tissue sarcoma - an analysis of the EORTC 62012 study
2015
·
V. Grünwald
, S. Litiere
, et al.
·
European Journal of Cancer
·
2
EORTC SPECTA-AYA: A molecular profiling platform for adolescents and young adults with cancer in Europe
2019
·
T. de Rojas
, B. Kasper
, et al.
·
Annals of Oncology
·
1
PDF
Efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma
2017
·
W.H.W. Chew
, W. van der Graaf
, et al.
·
Annals of Oncology
·
1
PDF
Diagnostic delay in primary osteosarcoma (OST) and Ewing sarcoma (ES) of bone in relation to metabolic activity on FDG PET/CT
2017
·
A. Van de Luijtgaarden
, E. Usmanij
, et al.
·
European Journal of Cancer
·
1
Online support community AYA4 (All information You have Asked for) for adolescents and young adults (AYAs) with cancer: evaluation and content analysis
2017
·
S. Kaal
, F. Van Dartel
, et al.
·
European Journal of Cancer
·
1
Severe fatigue in adolescent and young adult (AYA) cancer patients: prevalence, impact on quality of life (QOL), and associated factors
2017
·
H. Poort
, S. Kaal
, et al.
·
European Journal of Cancer
·
1
Neoadjuvant chemotherapy for radiotherapy associated angiosarcoma (RAAS) of the breast improves oncological outcomes
2024
·
S. Van Der Burg
, S. Reijers
, et al.
·
European Journal of Surgical Oncology
60P The diagnostic pathway of sarcoma patients: Results from the QUEST study in the Netherlands and the United Kingdom: A cohort study
2023
·
E. Holthuis
, V. Soomers
, et al.
·
ESMO Open
PDF
3167 Clustering of EORTC QLQ-C30 health-related quality of life scales across several disease sites
2020
·
A Machingura
, Jammbe Z. Musoro
, et al.
·
White Rose Research Online (University of Leeds, The University of Sheffield, University of York)
Health-related quality of life in sarcoma patients: enhancing personalized medicine.
2018
·
W. Van der Graaf
Exploring the potential for PD-1 blockade in sarcoma patients
2017
·
A. Van Erp
, Y. Versleijen-Jonkers
, et al.
·
European Journal of Cancer
PO-0765: Management of primary cardiac and great vessel sarcomas, The RMH experience 2000-2015
2016
·
R. Rieu
, C. Benson
, et al.
·
Radiotherapy and Oncology
PDF
1564 No need for gate keeping by professionals: Cancer patients want to be informed about intervention studies targeting fatigue
2015
·
H. Poort
, M. Peters
, et al.
·
European Journal of Cancer
3443 Severe fatigue in GIST patients: Prevalence, impact and factors associated with fatigue
2015
·
H. Poort
, M. Gielissen
, et al.
·
European Journal of Cancer
532 Skin infiltrating lymphocytes as an early biomarker to predict clinical outcome in stage III melanoma patients receiving adjuvant dendritic cell vaccination
2015
·
S. Boudewijns
, K. Bol
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
28
Citation count:
2,974
H-index:
8
I10-index:
8
Year
Topic
Type
